{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:35:08Z","timestamp":1774611308766,"version":"3.50.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1996,5]]},"DOI":"10.1212\/wnl.46.5.1258","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:19:55Z","timestamp":1336915195000},"page":"1258-1258","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":52,"title":["Cataplexy and monoamine oxidase deficiency in Norrie disease"],"prefix":"10.1212","volume":"46","author":[{"given":"D. G.","family":"Vossler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. R.","family":"Wyler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. J.","family":"Wilkus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gardner-Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. W.","family":"Vlcek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"1","volume":"111","year":"1993","unstructured":"Wong F, Goldberg MF, Hao Y. Identification of a nonsense mutation at codon 128 of the Norrie's disease gene in a male infant. Arch Ophthal 1993;111:1553\u20131557.","journal-title":"Arch Ophthal"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320450104"},{"key":"e_1_3_1_4_2","first-page":"3","volume":"2","year":"1991","unstructured":"Joy JE, Poglod R, Murphy DL, et al. Abnormal protein in the cerebrospinal fluid of patients with a submicroscopic X-chromosomal deletion associated with Norrie disease: preliminary report. Appl Theo Electrophor 1991;2:3\u20135.","journal-title":"Appl Theo Electrophor"},{"key":"e_1_3_1_5_2","first-page":"2","volume":"1","year":"1992","unstructured":"Chen Z-Y, Hendriks RW, Jobling MA, et al. Isolation and characterization of a candidate gene for Norrie disease. Nature Genet 1992;1:204\u2013208.","journal-title":"Nature Genet"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6974(94)00014-Q"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(86)80064-9"},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","unstructured":"Sheps SG Jiang N Klee GG. Diagnostic evaluation of pheochromocytoma. Endocrinol Metab Clin North Am 1988;17: 397\u2013414.","DOI":"10.1016\/S0889-8529(18)30426-2"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01244447"},{"key":"e_1_3_1_10_2","first-page":"2","volume":"16","year":"1976","unstructured":"Murphy DL, Wright C, Buchshaum M, Nichols A, Costa JL, Wyatt RJ. Platelet and plasma amine oxidase activity in 680 normals: sex and age differences and stability over time. Biochem Med 1976;16:254\u2013265.","journal-title":"Biochem Med"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0992-1"},{"key":"e_1_3_1_12_2","first-page":"2","volume":"9","year":"1993","unstructured":"Bateman JB, Kojis TL, Cantor RM, et al. Linkage analysis of Norrie disease with an X-chromosomal ornithine aminotransferase locus. Trans Am Ophthalmol SOC 1993;9:299\u2013308.","journal-title":"Trans Am Ophthalmol SOC"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320420102"},{"key":"e_1_3_1_14_2","first-page":"1","volume":"2","year":"1989","unstructured":"Sims KB, de la Chapelle A, Norio R, et al. Monoamine oxidase deficiency in males with an X chromosome deletion. Neuron 1989;2:1069\u20131076.","journal-title":"Neuron"},{"key":"e_1_3_1_15_2","unstructured":"Guilleminault C. Narcolepsy syndrome. In: Kryger MH Roth T Dement WC eds. Principles and practice of sleep medicine. 2nd ed. Philadelphia: WB Saunders 1994:549\u2013561."},{"key":"e_1_3_1_16_2","first-page":"S","volume":"17","year":"1994","unstructured":"Nishino S, Reid MS, Dement WC, Mignot E. Neuropharmacology and neurochemistry of canine narcolepsy. Sleep 1994;17:S84\u2013S92.","journal-title":"Sleep"},{"key":"e_1_3_1_17_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)10236-X","volume":"264","year":"1993","unstructured":"Nishino S, Fruhstorfer B, Arrigoni J, Guilleminault C, Dement WC, Mignot E. Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsy. J Pharmacol Exp Ther 1993;264:1079\u20131084.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_1_18_2","first-page":"4","volume":"16","year":"1993","unstructured":"Boivin DB, Montplaisir J, Petit D, Lambert C, Lubin S. Effects of modafinil on symptomatology of human narcolepsy. Clin Neuropharmacol 1993;16:46\u201353.","journal-title":"Clin Neuropharmacol"},{"key":"e_1_3_1_19_2","first-page":"3","volume":"23","year":"1993","unstructured":"Aldrich MS, Hollingsworth Z, Penney JB. Autoradiographic studies of post-mortem human narcoleptic brain. Neuro-physiol Clin 1993;23:35\u201345.","journal-title":"Neuro-physiol Clin"},{"key":"e_1_3_1_20_2","first-page":"2","volume":"45","year":"1995","unstructured":"Bodner RA, Lynch T, Lewis L, Kahn D. Serotonin syndrome. Neurology 1995;45:219\u2013223.","journal-title":"Neurology"},{"key":"e_1_3_1_21_2","first-page":"2","volume":"42","year":"1992","unstructured":"Kish SJ, Mamelak M, Slimovitch C, et al. Brain neurotransmitter changes in human narcolepsy. Neurology 1992;42:229\u2013234.","journal-title":"Neurology"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.1994.30"},{"key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)24293-8","volume":"272","year":"1995","unstructured":"Nishino S, Shelton J, Renaud A, Dement WC, Mignot E. Effect of 5-HTlA receptor agonists and antagonists on canine cataplexy. J Pharmacol Exp Ther 1995;272:1170\u20131175.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.46.5.1258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T22:19:40Z","timestamp":1743113980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.46.5.1258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,5]]}},"alternative-id":["10.1212\/WNL.46.5.1258"],"URL":"https:\/\/doi.org\/10.1212\/wnl.46.5.1258","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,5]]}}}